Avita Medical | 1811094D - Fremdkapital

Aktienkurs
1.08
Täglich Wechseln
-0.01 -0.64%
Monatlich
-20.66%
Jährlich
-58.51%
Q2 Prognose
1.07




Fremdkapital Veränderung Datum
Accuray USD 127.32M 3.53M 2025-09
Celltrion KRW 63.29B 4.01B 2025-09
Clinuvel Pharmaceuticals AUD 17.25K 80.1K 2025-12
Cochlear AUD 200M 6.5M 2025-12
CSL USD 10.42B 273M 2025-12
Cspc Pharmaceutical CNY 180.69M 21.94M 2025-12
Deva Holding AS TRY 559.97M 44.39M 2023-09
Dianthus Therapeutics USD 0 0 2024-12
Divis Laboratories Ltd INR 20M 0 2025-03
Kangmei Pharma CNY 78.45M 5.8M 2025-09
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Laboratorios Farma EUR 80.5M 28.26M 2024-12
Malin Corporation EUR 0 0 2024-12
Mayne Pharma AUD 2.66M 153K 2025-06
Medical Developments International AUD 1.5M 167K 2025-12
Nanosonics AUD 3.21M 1.06M 2025-12
Organigram Holdings CAD 62.52M 13.88M 2025-12
Ovoca Bio EUR 0 0 2021-06
Pacific Edge NZD 551K 637K 2025-12
Paradigm Biopharmaceuticals AUD 436.81K 336.81K 2025-12
Pharma Mar EUR 36.68M 1.07M 2025-12
Polynovo AUD 15.39M 663K 2025-12
PYC Therapeutics AUD 436.93K 188.06K 2025-12
Qiagen NV USD 1.65B 15.23M 2025-12
Ramsay Health Care AUD 11.2B 5.74B 2025-12
ResMed USD 403.92M 4.74M 2025-12
Sartorius EUR 3.41B 682.5M 2025-09
Sino Biopharmaceutical CNY 3.08B 1B 2025-06
Telix Pharmaceuticals AUD 448.45M 76.97M 2025-12
Tilray USD 268.59M 3.82M 2025-09
Zealand Pharma A/S 383.14M 727K 2025-12
Zz Pientze Pharmaceu CNY 186.56M 9.75M 2025-09